跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BI-EASE DUO ALLERGY azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle - TGA Drug Approval Details
Approvals
/
TGA
/
BI-EASE DUO ALLERGY azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle
Approved
STANDARD
BI-EASE DUO ALLERGY azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
8c147cc8aac38658
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
8c147cc8aac38658
Product Name
BI-EASE DUO ALLERGY azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle
Artg Id
415711
Artg Name
BI-EASE DUO ALLERGY azelastine (as hydrochloride) 125 microgram and fluticasone propionate 50 microgram nasal spray bottle
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2024-09-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
8c147cc8aac38658
Type
Standard
Back to TGA Approvals